SCHEMBL19932385

SCHEMBL19932385

Nc1ccn(C2O[C@H](CO)CC2(F)F)c(=O)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3A Q14432 3/20 0.62
▸ PDE4D Q08499 1/20 0.62
▸ SLC29A1 Q99808 1/20 0.62
▸ LMNA P02545 4/20 0.51
▸ CACNA1F O60840 2/20 0.51
▸ ALB P02768 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ CACNA1D Q01668 2/20 0.51
▸ CACNA1S Q13698 2/20 0.51
▸ CACNA1C Q13936 2/20 0.51
▸ THRB P10828 1/20 0.50
▸ MTOR P42345 1/20 0.50
▸ MDM2 Q00987 1/20 0.50
▸ NCOA1 Q15788 1/20 0.50
▸ NCOA3 Q9Y6Q9 1/20 0.50
▸ POLA1 P09884 2/20 0.43
▸ NT5E P21589 1/20 0.38
▸ POLG P54098 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ FGFR1 P11362 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912374 1.00 PDE3A (0.62) PDE3APDE4DSLC29A1LMNACACNA1F
SCHEMBL13713969 1.00 PDE3A (0.62) PDE3APDE4DSLC29A1LMNACACNA1F
SCHEMBL6153492 0.89 PDE3A (0.61) PDE3APDE4DSLC29A1LMNACACNA1F
SCHEMBL13487257 0.88 PDE3A (0.60) PDE3APDE4DSLC29A1LMNACACNA1F
SCHEMBL15189232 0.88 PDE3A (0.60) PDE3APDE4DSLC29A1LMNACACNA1F
SCHEMBL13813007 0.88 PDE3A (0.60) PDE3APDE4DSLC29A1LMNACACNA1F
SCHEMBL14180581 0.88 PDE3A (0.60) PDE3APDE4DSLC29A1LMNACACNA1F
SCHEMBL18270531 0.86 PDE3A (0.49) PDE3APDE4DSLC29A1LMNACACNA1F
SCHEMBL24735360 0.85 PDE3A (0.50) PDE3APDE4DSLC29A1LMNACACNA1F
SCHEMBL26247475 0.85 PDE3A (0.50) PDE3APDE4DSLC29A1LMNACACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3545968-A1 MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3 KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2019-10-02 — — EP disclosed
EP-2858666-B1 MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3 KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
EP-2968382-B1 SUBSTITUTED GEMCITABINE BICYCLIC AMIDE ANALOGS AND TREATMENT METHODS USING SAME NUCORION PHARMACEUTICALS INC (US) 2018-03-07 — — EP disclosed
Send feedback